Italia markets close in 7 hours

ITCI Aug 2024 65.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
6,10+1,40 (+29,79%)
Alla chiusura: 09:37AM EDT
Schermo intero
Chiusura precedente4,70
Aperto6,10
Denaro0,00
Domanda0,00
Prezzo d'esercizio65,00
Scadenza2024-08-16
Min-Max giorno6,10 - 6,10
Contratto - Min-MaxN/D
Volume8
Open InterestN/D
  • GlobeNewswire

    Intra-Cellular Therapies to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

    NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the 2023 Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2023 at 1:15 p.m. ET. The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company

  • GlobeNewswire

    Intra-Cellular Therapies to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

    NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday, September 12, 2023 at 12:55 p.m. ET. The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Comp

  • GlobeNewswire

    Intra-Cellular Therapies to Present at the Canaccord Genuity 43rd Annual Growth Conference

    NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023 at 1:30 p.m. ET. The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's websit